eISSN: 1994-4624 / ISSN: 1813-176x
Register
Login
International Journal of Molecular Medicine and Advance Sciences
2005, Volume 1, Issue 2 : 182-189 doi: ijmmas.2005.182.189
Research Article
Evaluation of the Antibacterial Properties of Picralima Nitida Stembark Extracts
Published
June 30, 2005
Abstract

The antibacterial activity of the alcohol extract of the stembark of Picralima nitida was tested against Staphylococcus aureus ATCC12600, Pseudomonas aeruginosa ATCC 10145, Bacillus subtilis ATCC 6051, Escherichia coli ATCC 11775, Salmonella kintambo Human 1,13,23 mt: and three clinical isolates. The antibacterial assay was by both the agar-well diffusion and macro-broth dilution methods. Separation of the crude extract by column chromatography yielded six fractions of which, all contained alkaloid except F . The spectra of activity for the crude extract and active fractions was 50% each, with no apparent activity recorded against the clinical isolates. Fractions F and F exhibited no antibacterial activity. The control drug, Gentamicin 1 5 had 62.5% spectrum of activity. There was significant difference (p<0.05) in antibacterial activity between the crude extract and its fractions, with F exhibiting the highest antibacterial activity. The MIC range for the crude was 25-50 mgmLG ; F , 3.125-50 mgmLG ; F , 1.563-50 mgmLG and F , 3.125-50 mgmLG . The combined activity of the fractions showed that the active components might be antagonistic to one another. Both the MBC and kill-rate study show that the partially purified fractions had higher bactericidal effect as compared to the crude extract. These results provide scientific justification for the use of locally distilled alcohol, as solvent for most herbal preparations.

Keywords
License
Copyright (c) International Journal of Molecular Medicine and Advance Sciences
Creative Commons Attribution License Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
Int. J. Mol. Med. Adv. Sci. open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Recommended Articles
Clinical Efficacy of Drug-Eluting Stents Among Hypertensive Patients
41-45
Occupational Health Risks Among Healthcare Workers: Prevalence, Determinants, Clinical Consequences, and Prevention Strategies
1-4
Healthcare Disparities and Equity in Medical Services: Challenges, Determinants, and Strategies for Achieving Equitable Healthcare
27-34
Professionalism and Ethics Education in Medical Schools: Assessing Knowledge, Attitudes, and Educational Outcomes Among Medical Students
16-20
International Journal of Molecular Medicine and Advance Sciences
+447480266638
+447480266638
support@ijmmas.com
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives (CC BY-NC-ND) license. Open Access Publication.
Copyright © ©International Journal of Molecular Medicine and Advance Sciences. All rights reserved.